Results 191 to 200 of about 86,493 (358)

Early Endothelial Activation in a Mouse Model of Graft vs Host Disease Following Chemotherapy. [PDF]

Front Immunol, 2021
Pereira M, Lee NT, Noonan J, Willcox AEH, Calvello I, Georgy SR, Selan C, Chia JS, Hauw W, Wang X, Peter K, Robson SC, Nandurkar HH, Sashindranath M.   +13 more
europepmc   +1 more source

Have we made progress in the management of chronic graft-vs-host disease? [PDF]

, 2010
Stephanie J. Lee
openalex   +1 more source

Peri‐implantitis reconstructive treatment implementing a titanium brush: 5‐year extension results from a randomized clinical trial

Journal of Periodontology, EarlyView.
Abstract Background Peri‐implantitis has become an important health issue in implant dentistry in the past years. Despite the magnitude of this problem and the potential grave consequences, the predictability and long‐term stability of its treatment is still a matter of controversy.
Beatriz de Tapia, Tiago Ribeiro‐Amaral, Carolina Mor, José Nart, Cristina Valles   +4 more
wiley   +1 more source

Case Report: Diagnosis and successful treatment of a rare case of steroid-refractory chronic graft-vs-host disease-related serositis. [PDF]

Front Immunol
Xiong Z, Wang Z, Chen X.
europepmc   +1 more source

Analysis of Antibiotic Exposure and Development of Acute Graft-vs-Host Disease Following Allogeneic Hematopoietic Cell Transplantation.

JAMA Netw Open, 2023
Rashidi A, Gao F, Fredricks DN, Pergam SA, Mielcarek M, Milano F, Sandmaier BM, Lee SJ.   +7 more
europepmc   +1 more source

Overlapping immune responses in donor lymphocyte infusion (DLI)-associated graft-vs-host disease

, 2004
Allan D. Hess, Yuji Miura, Emilie C. Bright, Christopher J. Thoburn, Georgia B. Vogelsang   +4 more
openalex   +1 more source

Drug Hypersensitivity: A Correlation Study From Histopathology to Clinic

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Drug hypersensitivity (DH) can present with varied clinical and pathological manifestations that may mislead the referring physician. Available data regarding the concordance between pathological diagnosis and clinical findings in DH are scarce.
Olivier Philip, Morgane Stichelbout, Marie Verhasselt‐Crinquette, Baptiste Mille, Delphine Staumont‐Sallé, Frédéric Dezoteux   +5 more
wiley   +1 more source

Sex differences in donor T cell targeting of host splenocyte subpopulations in acute and chronic murine graft-vs-host disease: results from a novel induction and assessment protocol with implications for lupus-like autoimmunity. [PDF]

Immunohorizons
Soloviova K, Via CS.
europepmc   +1 more source

Successful treatment of intractable gastrointestinal tract graft-vs-host disease with oral beclomethasone dipropionate in pediatric and young adult patients: Case reports. [PDF]

Medicine (Baltimore), 2022
Akahane K, Watanabe A, Somazu S, Harama D, Shinohara T, Kasai S, Oshiro H, Goi K, Hasuda N, Ozawa C, Sugita K, Inukai T.   +11 more
europepmc   +1 more source

Cyclosporine A and Mycophenolate Mofetil vs Cyclosporine A and Methotrexate for graft-versus-host disease prophylaxis after stem cell transplantation from HLA-identical siblings

, 2005
Frank Neumann, Thorsten Graef, Christoph Tapprich, Matthias Vaupel, Ulrich Steidl, Ulrich Germing, Roland Fenk, Axel Hinke, Rainer Haas, Guido Kobbe   +9 more
openalex   +1 more source